NMN/NR (Nicotinamide Mononucleotide/Riboside) Cost in Oregon 2026

How Much Does NMN/NR Cost in Oregon in 2026?
At a glance
- Average Oregon retail cash-pay price / approximately $80 per month (2026)
- Standard dosing / once daily oral capsule or sublingual
- Oregon Medicaid / covered with prior authorization
- Compounded NMN (503A pharmacy) / legal and available in Oregon
- Telehealth prescribing / permitted statewide
- Manufacturer list price / $0 per month (supplement classification)
- Most common forms / oral capsule, sublingual tablet
- Insurance coverage / varies by plan; most commercial plans exclude NAD precursors
- Typical supply / 30-day fills at retail and compounding pharmacies
- Savings programs / manufacturer discount cards, compounding pharmacy bundles
Oregon Retail Pharmacy Pricing for NMN/NR
The average cash-pay price for NMN across Oregon retail pharmacies sits at approximately $80 per month in 2026. That figure covers a standard 30-day supply of once-daily oral capsules or sublingual tablets. Prices shift depending on the specific pharmacy chain, location within the state, and whether you fill in a metro area like Portland versus a smaller town.
Price Variation by Oregon Region
Pharmacies in the Portland-Salem-Eugene corridor tend to cluster near that $80 average. Rural pharmacies in eastern Oregon or along the coast may charge $10 to $20 more due to lower volume and higher supply-chain costs. Costco and Amazon Pharmacy locations in Oregon sometimes undercut independent pharmacies by 10 to 15 percent for cash-pay customers.
NR (Nicotinamide Riboside) Pricing Comparison
NR products like Tru Niagen (nicotinamide riboside chloride) occupy a slightly different price band. A 30-day supply of NR 300 mg typically runs $40 to $50 at Oregon retail pharmacies. The price gap between NMN and NR reflects differences in manufacturing cost and patent positioning rather than a proven clinical superiority of one molecule over the other. A 2021 study by Yoshino et al. Published in Science (N=25) demonstrated that NMN at 250 mg/day improved muscle insulin sensitivity in prediabetic women, though the trial was small and short-term [1].
What Drives the Cash-Pay Price
NMN and NR sit in a regulatory gray zone. The FDA has not approved either molecule as a prescription drug through the standard New Drug Application pathway. Because NMN was sold as a dietary supplement before any Investigational New Drug application was filed, its legal status has been the subject of ongoing FDA review [2]. This regulatory ambiguity means pricing is not governed by the same competitive generic-market forces that drive down costs for drugs like metformin or lisinopril.
Oregon Medicaid Coverage for NMN/NR
Oregon Medicaid (Oregon Health Plan) covers NMN/NR with prior authorization. That means your prescribing clinician must submit documentation showing medical necessity before the state will approve payment. Not every PA request is approved, and the process can take 5 to 14 business days.
How to Get Prior Authorization Approved
The PA process for NAD precursors under Oregon Medicaid typically requires documentation of a specific clinical indication. Requests tied to age-related metabolic decline, mitochondrial dysfunction, or NAD depletion documented by lab work (such as intracellular NAD+ assays) have higher approval rates than vague "longevity" or "anti-aging" justifications.
Your clinician should include:
- A diagnosis code linked to a recognized condition (metabolic syndrome, insulin resistance, or documented NAD deficiency)
- Lab results showing relevant biomarker abnormalities
- A treatment history demonstrating that first-line interventions (lifestyle modification, standard metabolic medications) were tried or considered
- A specific dosing plan with follow-up timeline
Denial and Appeal Process
If Oregon Medicaid denies the PA, you have the right to appeal. The Oregon Health Authority publishes appeal timelines and forms on its website. A peer-to-peer review between your prescriber and the Medicaid medical director can sometimes overturn an initial denial within 48 hours.
Compounded NMN Through Oregon 503A Pharmacies
Compounded nicotinamide mononucleotide is legal in Oregon through licensed 503A compounding pharmacies. These pharmacies prepare NMN formulations based on individual prescriptions, which allows for customized dosing, combination formulations (such as NMN plus resveratrol or NMN plus TMG), and alternative delivery forms like sublingual troches or nasal sprays.
How 503A Compounding Works
A 503A pharmacy compounds medications for individual patients based on a valid prescription. Oregon Board of Pharmacy regulations require these pharmacies to maintain licensure, follow USP compounding standards, and source pharmaceutical-grade raw materials. The key distinction from 503B outsourcing facilities is that 503A pharmacies cannot produce large batches without patient-specific prescriptions.
Compounded NMN Pricing in Oregon
Compounded NMN pricing varies widely by pharmacy, formulation, and dose. Some Oregon compounding pharmacies advertise NMN capsules at $60 to $100 for a 30-day supply, while more complex formulations (liposomal NMN, combination products) may run $120 to $180 per month. Sublingual formulations designed for faster absorption often carry a small premium over standard capsules.
A 2022 systematic review in Ageing Research Reviews found that NAD+ precursor supplementation raised blood NAD+ levels by 40 to 90 percent in healthy adults across multiple small trials, though long-term clinical outcomes data remains limited [3]. The Endocrine Society has not issued formal guidelines on NAD+ precursor prescribing, which means compounding pharmacies and prescribers operate without a standardized dosing framework [4].
Insurance Coverage Beyond Medicaid
Most commercial insurance plans in Oregon do not cover NMN or NR. The reason is straightforward: without FDA approval as a prescription drug, insurers classify NAD precursors as supplements or experimental therapies, both of which fall outside standard formulary coverage.
Plans That May Offer Partial Coverage
Some Oregon-based employer health plans with integrative medicine riders or longevity-focused benefits may reimburse a portion of NMN costs. These are uncommon but growing. If your employer offers a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use those pre-tax dollars to pay for NMN if your provider writes a letter of medical necessity. The IRS allows HSA/FSA reimbursement for supplements prescribed to treat a specific medical condition.
Oregon Health Plan (OHP) vs. Commercial Plans
Oregon Medicaid's willingness to cover NMN with PA puts it ahead of most commercial insurers in the state. This counterintuitive situation exists because OHP's prioritized list of health services can accommodate treatments that address documented metabolic conditions, while commercial formulary committees tend to apply blanket exclusions for non-FDA-approved products.
Dr. Charles Brenner, who discovered nicotinamide riboside as a vitamin precursor to NAD+, has stated: "The question is not whether NAD+ declines with age. It does. The question is whether boosting it with a precursor produces durable clinical benefits" [5]. That unresolved question is precisely why most insurers remain on the sidelines.
Telehealth Access to NMN/NR in Oregon
Oregon permits telehealth prescribing of NMN/NR with no geographic restrictions within the state. After the permanent telehealth expansions that followed Oregon House Bill 2508, clinicians licensed in Oregon can evaluate patients, order relevant labs, and prescribe NAD precursors entirely through video or audio visits.
How Telehealth Prescribing Works for NMN
A typical telehealth NMN consultation involves:
- An initial video visit (15 to 30 minutes) where the clinician reviews your health history, current medications, and goals
- Lab orders if the clinician wants baseline NAD+, metabolic panel, or liver function data
- A prescription sent electronically to a retail or compounding pharmacy of your choice in Oregon
- Follow-up visits at 60- to 90-day intervals to assess response and adjust dosing
Advantages for Rural Oregon Residents
For patients in Bend, Medford, Klamath Falls, or the rural eastern half of the state, telehealth eliminates the need to drive hours to reach a prescriber familiar with NAD+ precursor therapy. Several telehealth platforms operating in Oregon now include NMN/NR in their longevity-medicine offerings, with consultation fees ranging from $99 to $250 for an initial visit.
Saving Money on NMN/NR in Oregon
Multiple strategies can reduce your out-of-pocket cost below the $80/month retail average.
Manufacturer Discount and Savings Cards
Several NMN and NR manufacturers offer savings cards or subscription discounts. These programs typically reduce the per-month cost by 15 to 30 percent for patients who commit to a 3- or 6-month supply. Because NMN does not have a single branded manufacturer in the traditional pharmaceutical sense, "manufacturer" here refers to the companies producing prescription-grade or pharmaceutical-grade NMN products.
Compounding Pharmacy Bundles
Oregon compounding pharmacies sometimes offer multi-month pricing that brings per-month costs down to $50 to $70. Asking about 90-day fills rather than 30-day fills can also reduce per-unit cost. Some pharmacies discount combination products (NMN plus TMG, or NMN plus pterostilbene) relative to ordering each ingredient separately.
Comparing NMN vs. NR on Cost
If your clinician considers NMN and NR interchangeable for your situation, NR may save you $30 to $40 per month at Oregon pharmacies. A randomized crossover trial published in Nature Communications found that both NMN and NR raised whole-blood NAD+ comparably at matched doses, though tissue-specific distribution may differ [6]. Discuss with your prescriber whether the cost savings justify a switch.
Patient Assistance and Free Programs
No formal patient assistance program exists for NMN from a single manufacturer, unlike branded pharmaceuticals such as Ozempic or Wegovy. However, some longevity-focused clinics in Oregon offer income-based sliding-scale pricing for consultations, reducing the total cost of care even if the medication price stays the same.
What the Science Says About NMN/NR Value
Understanding the evidence base helps you decide whether NMN/NR is worth the monthly investment.
Key Clinical Data
The Yoshino et al. Trial in Science (2021) enrolled 25 postmenopausal, prediabetic women and showed that 250 mg/day of NMN for 10 weeks improved skeletal muscle insulin signaling and glucose uptake compared to placebo [1]. The effect size was meaningful but the sample was small.
A separate 12-week RCT published in the New England Journal of Medicine correspondence section examined NR at 1,000 mg/day in 40 middle-aged adults with obesity and found a 60% increase in blood NAD+ but no significant change in insulin sensitivity or body composition [7]. These mixed results underline that NAD+ elevation does not automatically translate to metabolic improvement.
Where the Evidence Gaps Are
No large (N > 500), long-duration (> 1 year) RCT has been published for either NMN or NR as of mid-2026. The National Institute on Aging lists several ongoing trials, but results are not expected before 2027 or 2028 [8]. The American Academy of Anti-Aging Medicine acknowledges NAD+ precursors as "promising" but stops short of formal endorsement pending larger trials.
As the NIH National Institute on Aging has noted: "While preclinical data on NAD+ repletion is strong, translating these findings to human healthspan requires adequately powered clinical trials" [8].
Practical Steps to Start NMN/NR in Oregon
Getting started requires a prescription, a pharmacy, and a plan for monitoring.
Step-by-Step Process
- Schedule a visit (in-person or telehealth) with a clinician who prescribes NAD+ precursors
- Complete baseline labs: metabolic panel, liver enzymes, and optional intracellular NAD+ levels
- Receive your prescription for NMN (typically 250 to 500 mg daily) or NR (250 to 1,000 mg daily)
- Choose a pharmacy: retail for convenience, or 503A compounding for customized formulations
- Fill your first 30-day supply and begin daily dosing (morning, with or without food)
- Return for follow-up labs and clinical assessment at 8 to 12 weeks
Oregon residents with OHP coverage should ask their prescriber to initiate the prior authorization process at step 2, since PA approval can take up to 14 business days. Starting the paperwork early prevents gaps between your first visit and your first fill.
The standard dose form is a once-daily oral capsule or sublingual tablet taken in the morning.
Frequently asked questions
›How much does NMN/NR cost in Oregon?
›Does Oregon Medicaid cover NMN/NR?
›Is compounded nicotinamide mononucleotide legal in Oregon?
›Can I get NMN/NR via telehealth in Oregon?
›Which insurance plans cover NMN/NR in Oregon?
›What's the cheapest way to get NMN/NR in Oregon?
›Are there Oregon NMN/NR discount programs?
›How does a savings card work for NMN in Oregon?
›What dose of NMN is typically prescribed in Oregon?
›Do I need lab work before starting NMN in Oregon?
References
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
- U.S. Food and Drug Administration. Dietary Supplement Ingredient Advisory List. https://www.fda.gov/food/dietary-supplement-ingredient-directory/dietary-supplement-ingredient-advisory-list
- Reiten OK, Wilvang MA, Mitchell SJ, et al. Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Mech Ageing Dev. 2021;199:111567. https://pubmed.ncbi.nlm.nih.gov/34517020/
- Endocrine Society. Endocrine Society Scientific Statements. https://www.endocrine.org/clinical-practice-guidelines
- Brenner C. Nicotinamide riboside and NAD+ metabolism in human health. Nat Metab. 2023. https://pubmed.ncbi.nlm.nih.gov/36635583/
- Pencina KM, Lavu S, Dos Santos M, et al. MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, increases circulating NMN and NAD in a randomized clinical trial. npj Aging. 2023;9:25. https://pubmed.ncbi.nlm.nih.gov/37935871/
- Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. J Clin Endocrinol Metab. 2018;103(12):4357-4366. https://pubmed.ncbi.nlm.nih.gov/30124511/
- National Institute on Aging. Research on NAD+ and aging. National Institutes of Health. https://www.nih.gov/news-events/nih-research-matters